Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oligometastatic Prostate Carcinoma”

96 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 96 results

Early research (Phase 1)Active Not RecruitingNCT05079698
What this trial is testing

Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT04190446
What this trial is testing

Evaluate Hypofractionated Proton Therapy or IMRT for Recurrent, Oligometastatic Prostate Cancer

Who this might be right for
Metastatic Prostate AdenocarcinomaOligometastatic Prostate CarcinomaProstate Adenocarcinoma+2 more
Mayo Clinic 84
Early research (Phase 1)WithdrawnNCT03477864
What this trial is testing

Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer

Who this might be right for
Stage III Prostate CancerStage IIIA Prostate CancerStage IIIB Prostate Cancer+4 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Testing effectiveness (Phase 2)Active Not RecruitingNCT04619069
What this trial is testing

Intermittent Androgen Deprivation Therapy With or Without Stereotactic Body Radiotherapy for Molecularly Identified Hormone Sensitive Oligometastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Sunnybrook Health Sciences Centre 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05053152
What this trial is testing

Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study

Who this might be right for
Oligometastatic Prostate CarcinomaProstate AdenocarcinomaProstate Ductal Adenocarcinoma+2 more
NRG Oncology 194
Testing effectiveness (Phase 2)Active Not RecruitingNCT03902951
What this trial is testing

Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate AdenocarcinomaProstate Adenocarcinoma With Focal Neuroendocrine DifferentiationRecurrent Prostate Carcinoma+1 more
Jonsson Comprehensive Cancer Center 28
Not applicableStudy completedNCT02264379
What this trial is testing

Percutaneous High-dose Radiotherapy in Patients With Oligometastases of Prostate Carcinoma

Who this might be right for
Oligometastatic DiseaseProstate Cancer
Technische Universität Dresden 73
Testing effectiveness (Phase 2)Looking for participantsNCT05560659
What this trial is testing

Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy

Who this might be right for
Oligometastatic Prostate Cancer
Peter MacCallum Cancer Centre, Australia 92
Testing effectiveness (Phase 2)Looking for participantsNCT05223803
What this trial is testing

TERPS Trial for de Novo Oligometastic Prostate Cancer

Who this might be right for
Prostate CancerOligometastatic Disease
University of Maryland, Baltimore 122
Testing effectiveness (Phase 2)Study completedNCT04992026
What this trial is testing

The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer

Who this might be right for
ProstatectomyOligometastatic Prostate CancerAbiraterone
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT03569241
What this trial is testing

PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases

Who this might be right for
Prostate CancerProstate Cancer MetastaticMetastatic Cancer+1 more
University Hospital, Ghent 196
Testing effectiveness (Phase 2)Active Not RecruitingNCT04748042
What this trial is testing

Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)

Who this might be right for
Prostate CancerCastrate Sensitive Prostate CancerOligometastatic Disease
University of Michigan Rogel Cancer Center 21
Testing effectiveness (Phase 2)Study completedNCT02274779
What this trial is testing

Salvage Radiotherapy Combined With Hormonotherapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer

Who this might be right for
Prostate Cancer
Institut Cancerologie de l'Ouest 74
Not applicableActive Not RecruitingNCT03630666
What this trial is testing

Comparison of Intermittent Androgen Deprivation Therapy With or Without Irradiation Recovery in Prostate Cancer Patients

Who this might be right for
Prostate CancerOligometastasis
Institut Cancerologie de l'Ouest 256
Testing effectiveness (Phase 2)Looking for participantsNCT06387056
What this trial is testing

Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)

Who this might be right for
Locally Advanced Prostate CancerOligometastatic Prostate Cancer
The First Affiliated Hospital of Xiamen University 40
Early research (Phase 1)Looking for participantsNCT05997615
What this trial is testing

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

Who this might be right for
Hormone-refractory Prostate Cancer
Vir Biotechnology, Inc. 390
Testing effectiveness (Phase 2)Study completedNCT04037358
What this trial is testing

RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancers

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 64
Not applicableLooking for participantsNCT06462963
What this trial is testing

OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)

Who this might be right for
Breast CancerProstate CancerNSCLC+2 more
European Organisation for Research and Treatment of Cancer - EORTC 302
Early research (Phase 1)Active Not RecruitingNCT06229366
What this trial is testing

[Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Castration-resistant Prostate CancerOligometastatic Prostate Carcinoma+1 more
Eli Lilly and Company 142
Large-scale testing (Phase 3)Active Not RecruitingNCT04115007
What this trial is testing

Prostate-cancer Treatment Using Stereotactic Radiotherapy for Oligometastases Ablation in Hormone-sensitive Patients

Who this might be right for
Oligometastatic Hormone Sensitive Prostate Cancer
UNICANCER 550
Load More Results